CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 105 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $166,956,377 | +66.0% | 4,345,559 | 0.0% | 9.97% | +36.9% |
| Q1 2023 | $100,599,691 | -11.6% | 4,345,559 | 0.0% | 7.28% | +2.9% |
| Q4 2022 | $113,853,646 | +35.8% | 4,345,559 | +1.9% | 7.08% | +9.6% |
| Q3 2022 | $83,861,000 | +33.4% | 4,265,559 | +18.7% | 6.46% | +8.8% |
| Q2 2022 | $62,877,000 | +41.7% | 3,595,026 | +32.6% | 5.93% | +56.9% |
| Q1 2022 | $44,369,000 | – | 2,712,041 | – | 3.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parallel Advisors, LLC | 5 | $0 | 0.00% |